087 POTENTIATION OF SLEEP BENEFIT BY LONG-ACTING DOPAMINE AGONIST IN PARKINSON'S DISEASE

2009 ◽  
Vol 10 ◽  
pp. S24
Author(s):  
S. Katayama
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist ◽  
Sleep Benefit ◽  
Long Acting

Cabergoline: A long-acting dopamine agonist in Parkinson's disease

1990 ◽  
Vol 28 (4) ◽  
pp. 593-594 ◽  
Author(s):  
G. Lera ◽  
J. Vaamonde ◽  
J. Muruzabal ◽  
J. A. Obeso
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist ◽  
Long Acting

Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease

1995 ◽  
Vol 10 (5) ◽  
pp. 604-607 ◽  
Author(s):  
R. Inzelberg ◽  
P. Nisipeanu ◽  
M. J. Rabey ◽  
A. D. Korczyn
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist ◽  
Term Tolerability ◽  
Long Acting

Dual dopamine agonist treatment in Parkinson’s disease

2003 ◽  
Vol 250 (7) ◽  
pp. 822-826 ◽  
Author(s):  
Fabrizio Stocchi ◽  
Laura Vacca ◽  
Alfredo Berardelli ◽  
Marco Onofrj ◽  
Mario Manfredi ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Agonist

scholarly journals Sleep benefit in Parkinson's disease is associated with short sleep times

2014 ◽  
Vol 20 (1) ◽  
pp. 116-118 ◽  
Author(s):  
Eskender Sherif ◽  
Philipp O. Valko ◽  
Sebastiaan Overeem ◽  
Christian R. Baumann
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Short Sleep ◽  
Sleep Benefit
Sign in / Sign up

Export Citation Format

Share Document